FTC Secures $12M Settlement Over Edwards-JC Medical Deal
California-based Edwards Lifesciences and Singapore's Genesis Medtech agreed to pay a combined $12 million to settle claims from the Federal Trade Commission that Edwards attempted to evade the Hart-Scott-Rodino notification and...To view the full article, register now.
Already a subscriber? Click here to view full article